Back to Search
Start Over
Patient Reported Outcomes Show Newer Drug Combinations Maintain Quality of Life Longer Than Current Standard of Care Treatments.
- Source :
-
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2020 Feb 20; Vol. 34 (2), pp. 61-62. - Publication Year :
- 2020
-
Abstract
- Multiple studies showed improved patient outcomes and increased quality of life among various treatments that previously demonstrated clinical benefits. these patient-centric findings, along with a promising new combination therapy for patients with advanced hepatocellular carcinoma highlight some of the latest research to come out of the 2020 Gastrointestinal Cancers Symposium.
- Subjects :
- Carcinoma, Hepatocellular pathology
Clinical Trials, Phase III as Topic
Humans
Liver Neoplasms pathology
Quality of Life
Randomized Controlled Trials as Topic
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Hepatocellular drug therapy
Drugs, Investigational therapeutic use
Liver Neoplasms drug therapy
Patient Reported Outcome Measures
Standard of Care standards
Subjects
Details
- Language :
- English
- ISSN :
- 0890-9091
- Volume :
- 34
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Oncology (Williston Park, N.Y.)
- Publication Type :
- Academic Journal
- Accession number :
- 32645197